SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is seeing intense retail and institutional focus as investors speculate on a short squeeze fueled by high short interest and anticipation of key trial results. The community is heavily divided, with long-term holders dismissing bearish concerns about trial design and the efficacy of Best Available Therapy as 'FUD' while bulls aggressively anticipate a potential buyout or major data-driven price move.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense community debate, with bulls betting on a repeat of previous volatility and aggressive short-term price spikes, while skeptics point to repeated cycles of liquidity exhaustion and a lack of clear project updates. The conversation is heavily driven by traders debating whether the current volume patterns indicate a genuine breakout or just another opportunity for whales to manipulate price action.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market attention as traders monitor its recent breakout from a multi-month downtrend alongside institutional accumulation. The community is actively debating the stock's potential as a key player in AI-driven healthcare infrastructure while managing risks associated with short interest and recent price volatility.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing a strong recovery fueled by massive institutional accumulation and high trading volume during index rebalancing, further bolstered by reports of Michael Burry initiating bullish long-dated options positions. The community is actively debating whether this movement represents a sustainable trend reversal driven by fundamentally undervalued quality, or merely a short-term relief rally amidst broader sector rotation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant investor enthusiasm as the market re-rates the company from a legacy handset provider to a key foundational player in the physical AI, robotics, and software-defined vehicle sectors. Community sentiment is overwhelmingly bullish, fueled by strong earnings performance, a tightening float, and active discussions regarding the long-term potential of the QNX operating system and the upcoming Alloy Kore platform.

A composable native asset bridge with unified liquidity and instant guaranteed finality

Stargate

Stargate is capturing significant community attention as users debate the impact of its recent share buyback program and the potential for cross-chain liquidity growth through its integration with LayerZero. Investors are actively discussing the token's technical strength and its role in omnichain infrastructure, while others closely watch for volume surges to drive a sustained price rally.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is facing intensified scrutiny as investors express growing concerns over the massive capital expenditures required to sustain AI infrastructure and the recent departure of high-profile research talent to rivals. Despite this volatility, many in the community continue to view the stock as a long-term compounder, focusing on its dominant search monopoly and expanding cloud-computing cash flows as key indicators of its underlying value.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors digest news of high-profile AI talent departures to competitors, intensifying concerns regarding the company's ability to maintain its lead in the generative AI race. The stock is facing heightened volatility as market sentiment pivots toward scrutinizing the massive capital expenditures required for AI infrastructure amidst this competitive talent environment.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is trending as investors digest its utility within the reinsurance sector and respond to recent high-profile platform listings. The community is actively discussing the token's infrastructure-backed model, monitoring key support levels, and debating its potential for long-term growth versus short-term volatility.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is trending following the FDA approval and launch of Lumvoa, the first treatment for thyroid eye disease with labeling for both active and chronic forms of the condition. Community members are actively discussing the company's competitive positioning against existing blockbusters and are expressing strong interest in the upcoming conference call for updates on launch metrics and pricing strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
